QuikReader
QuikReader
Latest
Top stories
Business
Tech
World
Politics
Sports
Lifestyle
Health
Science
Entertainment
More
Sources
Sign in
Business
Sources
CNBC
US Top News and Analysis
Hims & Hers shares rise as company adds new weight-loss medications to platform
Hims & Hers is adding Zepbound, Mounjaro, and the generic injection liraglutide to its platform.
Read more at
CNBC
Save Story
Topics in this Story
New
Platform
NBC
Love
Hims Hers Shares
Related Stories
NYSE’s Texas platform debuts with Trump’s social media stock
Financial Times
· 2d
Donkey Kong: Bananza is a new platformer featuring Nintendo’s OG
VentureBeat
· 10h
Steve Kornacki exits MSNBC for new deal with NBC News and NBC Sports
Los Angeles Times
· 1d
‘Modern Love’ Podcast: My Brother Has Schizophrenia. This Is How I Love Him.
The New York Times
· 4h
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
CNBC
· 23h
My Daughter Doesn’t Want Me to Walk Her Down The Aisle
The New York Times
· 6d
30 years after her death, Selena's legacy is stronger than ever.
Los Angeles Times
· 2d
How George W. Bush responded to Jenna's offer to co-host with her
NBC News
· 2d
More from CNBC
Treasury Secretary Bessent says market woes are more about tech stock sell-off than Trump's tariffs
CNBC
· 1h
Apple leads a drop in tech stocks after Trump tariff announcement
CNBC
· 2h
Advertisers look for flexibility as they parse how Trump's new tariffs will affect their businesses
CNBC
· 1h
Amazon submits bid for TikTok as ban deadline nears
CNBC
· 3h
Trump's tariffs leave gadget makers in crisis: 'I'm going to run out of appliances'
CNBC
· 3h
More in Business
Senate Votes to Rescind Some Trump Tariffs, With G.O.P. Support
The New York Times
· 37m
Jim Cramer says Trump tariffs are more punitive than reciprocal
CNBC
· 50m
Trump’s tariffs in brief: universal levies and targeted retaliation
Financial Times
· 1h
Americans’ Reaction to Trump’s Tariffs Vary From Worried to Enthused
The New York Times
· 1h
Trump Unveils Expansive Global Tariffs
The New York Times
· 1h